Websites
-
Williams Group | Targeting Disease Pathways in Rheumatoid Arthritis
Research Group, Kennedy Institute
Richard Williams
Associate Professor
Richard Williams has worked at the Kennedy Institute of Rheumatology since 1989 and was a Senior Lecturer (2007-2011) and then Reader (2011-2012) at Imperial College London before joining the University of Oxford.
He is also a Visiting Lecturer at Queen Mary University of London and the London School of Hygiene and Tropical Medicine and was recently appointed as an Editor of Frontiers in Immunology.
He has established an internationally recognised reputation in translational research and his early studies were instrumental in the development of TNF blocking biologics.
He has carried out numerous projects with British and overseas industrial partners, including Merck, Pfizer, GSK, UCB, Schering, Celgene and J&J and has led an MRC DPFS project on rheumatoid arthritis.
Key publications
-
Journal article
Alzabin S. et al, (2012), Ann rheum dis, 71, 1741 - 1748
-
Journal article
Cribbs AP. et al, (2014), Arthritis rheumatol, 66, 2344 - 2354
-
Journal article
Criado G. et al, (2009), Arthritis rheum, 60, 1342 - 1351
-
Journal article
Notley CA. et al, (2008), J exp med, 205, 2491 - 2497
-
Journal article
Kawalkowska JZ. et al, (2019), Sci adv, 5
-
Journal article
McCann FE. et al, (2014), Arthritis rheumatol, 66, 2728 - 2738
Recent publications
-
Journal article
Al-Bogami M. et al, (2020), Rheumatology (oxford)
-
Journal article
Aungier S. et al, (2020), Ann rheum dis, 79
-
Journal article
Ogbechi J. et al, (2020), Exp gerontol, 131
-
Journal article
Tseng W-Y. et al, (2019), Proc natl acad sci u s a, 116, 21666 - 21672
-
Journal article
Kawalkowska JZ. et al, (2019), Sci adv, 5